Educational Content

This peer-reviewed publication offers key insights into improving CAR-T cell manufacturing by making smarter choices in raw materials. Learn how thoughtful selection of human-derived materials, automation technologies, and reliable suppliers can boost both the effectiveness and scalability of CAR-T therapies.

This infographic visually guides through the key stages of the manufacturing process of the CAR-T therapies, making complex workflows easier to understand. It also includes 2 essential layers of information: Human raw materials used in these processes and key regulatory recommendations.

This webinar aims to provide valuable insights into optimizing CAR-T cell production through smarter raw material selection. Discover how strategic choices in these human raw materials, automation, and supplier selection can enhance the success and scalability of CAR-T cell therapies.

A reliable partner can be invaluable in navigating regulatory hurdles and optimizing your cell therapy manufacturing processes. We've compiled three key tips to consider when selecting a human serum albumin supplier.

This study explores how donor factors like body mass index (BMI) can affect leukopak quality (white blood cell yield and viability). Understanding the factors is crucial for ensuring consistent product quality across different collection centers. Download to learn more!

This poster explores how the use of recallable donors can reduce variability in leukopak collections, enhance standardization, and improve the reliability of preclinical studies. Click here to learn more!